Welcome to our dedicated page for Healthcare Triangle news (Ticker: HCTI), a resource for investors and traders seeking the latest updates and insights on Healthcare Triangle stock.
Healthcare Triangle, Inc. reports developments in healthcare information technology, digital health platforms, cloud enablement, managed services, and data analytics for healthcare and life sciences organizations. Company news includes product and customer updates involving hospital information management, interoperability, telehealth, AI-powered clinical and operational automation, and customer-engagement tools.
Recurring HCTI updates also cover subsidiary activity at QuantumNexis, international expansion across Africa, the Middle East, and related healthcare markets, partnership and joint-venture activity, and capital-structure actions such as share repurchase authorization and reverse stock split disclosures.
Healthcare Triangle (Nasdaq: HCTI) announced its participation in ViVE 2023, held March 26-29 in Nashville, Tennessee. This event gathers leaders from digital healthcare sectors. HCTI will host a “Tech Talk” with Melissa Hall, Chief Nursing Officer at CalvertHealth, on March 27, showcasing their HITRUST Certified Data EHR Resiliency Solution. This solution significantly reduced CalvertHealth’s disaster recovery time from 72 hours to under 2 hours. HCTI's leadership emphasizes operational efficiency and cost-effectiveness through digital transformation solutions, reinforcing their commitment to enhancing healthcare outcomes.
Healthcare Triangle, Inc. (HCTI) has announced that it does not hold any cash or maintain accounts at Silicon Valley Bank (SVB), nor does it have any business relationship with SVB. This clarification comes amidst broader market concerns regarding SVB’s financial stability. HCTI is a provider of cloud solutions and data analytics for the healthcare sector, emphasizing its HITRUST Certification for data protection. The company expresses confidence in its technology and industry expertise, aimed at aiding healthcare providers in improving health outcomes.
Healthcare Triangle (Nasdaq: HCTI) has successfully assisted Floyd County Medical Center (FCMC) in implementing the MEDITECH Expanse platform. FCMC, a 25-bed critical access hospital in Iowa, transitioned from a hybrid EHR system to a unified digital solution. The project involved digitizing both paper and electronic records and modernizing workflows in clinical, billing, and financial systems.
Healthcare Triangle's consultants provided essential support to avoid errors and ensure successful outcomes. The MEDITECH Expanse implementation has enabled FCMC to improve patient care, facilitate timely care decisions, and enhance overall efficiency.
Healthcare Triangle, Inc (HCTI) reported a 48% revenue increase in Q3 2022, achieving $11.9 million compared to $8.1 million in the same period last year. The gross margin stood at 29%, with R&D costs of $1.5 million. The company raised $6.5 million via private placement and launched services in Singapore. Despite the growth, HCTI posted a net loss of $2.3 million or $(0.06) per share, while cash on hand was $4.1 million as of September 30, 2022.
Healthcare Triangle Inc. (Nasdaq: HCTI) has unveiled its services aimed at integrating Metaverse technologies into healthcare and life sciences. The market for Metaverse in healthcare is projected to reach USD 5.3 Billion by 2030, with a 48.3% CAGR. This initiative promises to enhance patient care through digital twins, real-time monitoring, and virtual engagements. HCTI's cloud-based platforms will support the implementation of these technologies, positioning the company favorably in the evolving healthcare landscape.
Healthcare Triangle has successfully implemented new functionality in MEDITECH Expanse for Chronic Care Management (CCM) at Lane Regional Medical Center. This initiative aims to enhance patient care for chronic conditions and improve value-based reimbursement.
With expert assistance from HCTI, Lane Regional transitioned from manual tracking to a streamlined process, resulting in improved efficiency, automated billing, and reduced administrative burdens. The project was completed in just four weeks, significantly enhancing care management capabilities.
Healthcare Triangle Inc. (Nasdaq: HCTI) announced that its Chairman and CEO, Suresh Venkatachari, will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. The presentation is scheduled for September 14 at 1:30 PM EDT, accompanied by one-on-one meetings with investors.
Healthcare Triangle focuses on leveraging technology to enhance healthcare outcomes for providers, payers, and life sciences organizations. The company has achieved HITRUST Certification for its Cloud and Data Platform, bolstering its commitment to data protection and security.
Healthcare Triangle Inc. (Nasdaq:HCTI) announced that its CEO, Suresh Venkatachari, will present at the 148th National Investment Banking Association (NIBA) conference on September 8, 2022, at Margaritaville Hollywood Beach Resort, Florida. The presentation will be followed by one-on-one meetings with investors. Healthcare Triangle specializes in enhancing healthcare through technology, achieving HITRUST Certification for its Cloud and Data Platform. The NIBA has a rich history of supporting the small-cap investment community, having hosted numerous investment conferences.
Healthcare Triangle (HCTI) has launched operations in Singapore, committing up to USD 25 million and creating over 500 jobs in the next five years. The company aims to enhance digital healthcare in the Asia Pacific region, which is expected to reach USD 100 billion by 2025. As a premier partner of major cloud services, Healthcare Triangle will leverage its expertise to support healthcare providers in their digital transformation journey. The digital health market in APAC is projected to grow from USD 40.3 billion in 2021 to USD 326.7 billion by 2030.
Healthcare Triangle (HCTI) announced the closing of a private placement with an institutional investor, issuing 6,097,561 shares of common stock at $1.066 each, generating approximately $6.5 million in gross proceeds. The transaction includes unregistered preferred investment options to purchase the same number of shares. Proceeds will be employed for working capital and general corporate purposes. H.C. Wainwright & Co. acted as the placement agent. The securities are offered under Section 4(a)(2) of the Securities Act and are subject to resale registration with the SEC.